Industry News
Biotechs, VCs need to get real, says UK venture capitalist
Both biotechnology companies and venture capitalists need to be more realistic about the opportunities and outcomes available to them, a British venture capitalist told a Melbourne forum yesterday. [ + ]
Criminalise human cloning, says new group
A newly-formed international consortium of scientists and lawyers has launched a bid to have human reproductive cloning declared a crime against humanity. [ + ]
Abbott disputes Peptech patent infringement
Peptech's shares (ASX:PTD) nose-dived today, dropping as low as AUD$1.23 after news that the company was embroiled in another patent dispute over its anti-TNF patents, this time with licensee Abbott Laboratories. [ + ]
Norwood on track for spin-off's UK listing
Norwood Abbey (ASX:NAL) is on track to list its immunology spin-off in the United Kingdom within six months. [ + ]
Cytochrome structure unravels photosynthesis
A complete molecular-scale picture of how plants convert sunlight to chemical energy has been obtained at Purdue University in the US, offering potential new insights into animal metabolism as well.
[ + ]GroPep finally closes Biotech Australia chapter
GroPep (ASX:GRO) has closed the book on its acquisition of Biotech Australia with the receipt of AUD$3.6 million final payment for the Roseville site. [ + ]
ComBio 2003: The hard truth about salt resistance
'Durum' means 'hard' in Latin -- but for wheatgrowers who have tried to grow high-value, high-protein durum wheats in the semi-arid regions of Victoria, SA an WA semi-arid zone, durum wheats are in the too-hard basket. [ + ]
Biotech demand will continue to grow: analyst
The recent upswing in biotech share prices has acted as a trigger point for the increase in investment in the sector, according to sector analyst and BioShares co-editor David Blake. [ + ]
IDG Life Sciences to launch new magazine
October marks the culmination of our plans to develop a comprehensive suite of life science media products for the Australian market place. Australian Biotechnology News is now well entrenched as the newspaper of choice for local biotechnology leaders. And our acquisition of Today's Life Science has given us great depth across the sector. [ + ]
Ventracor to benefit from US reimbursement decision
A United States decision to approve reimbursement of Ventricular Assist Devices has come as good news to Australian artificial heart developer Ventracor (ASX:VCR). [ + ]
pSivida raises $6.5m, raises stake in UK subsid
Biomedical nanotechnology company pSivida (ASX:PSD) will strengthen its stake in its United Kingdom operating subsidiary following a AUD$6.5 million capital raising, the biotech announced today. [ + ]
Optiscan receives first Pentax order
Optiscan Imaging's (ASX: OIL) partnership with Japan's Pentax Corporation to develop a flexible endomicroscope has taken another step forward with the Melbourne biotech receiving its first major order for the supply of components. [ + ]
Biota strengthens Sankyo agreement
Biota Holdings' (ASX:BTA) second-generation influenza program has leap-frogged into clinical trials thanks to a partnership with a Japanese competitor. [ + ]
New ARC scheme aims to create research networks
The Australian Research Council has launched a new program aimed at encouraging the development of research networks, and fostering interdisciplinary research. [ + ]
UK investors double EQiTX war chest
Technology investment company EQiTX (ASX:EQX) has more than doubled its cash reserves with a successful AUD$2.7 million capital raising, raised mostly through investors in the United Kingdom. [ + ]
